Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies CSO Laszlo Radvanyi Co-authors Study in Clinical Cancer Research

LOS ANGELES, Jan. 12, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL),...
January 06, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Present at Biotech Showcase

LOS ANGELES, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO) announced that president and CEO Elma Hawkins, PhD, will present at the Biotech Showcase on Monday, January 12, 2015....
January 05, 2015 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Submits Investigational New Drug Application to Conduct Phase 2 Study in Metastatic Melanoma

LOS ANGELES, Jan. 5, 2015 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies, today announced that it has filed an investigational...
December 22, 2014 16:01 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Closing of Underwritten Common Stock Offering

LOS ANGELES, Dec. 22, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating...
December 17, 2014 09:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Pricing of Underwritten Common Stock Offering

LOS ANGELES, Dec. 17, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
December 15, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Names Elma Hawkins President, Chief Executive Officer and Director

LOS ANGELES, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc., a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes (TIL), today...
December 08, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Positive New Data From Lead TIL Melanoma Program at ASH

LOS ANGELES, Dec. 8, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs)...
December 01, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies to Present at the Piper Jaffray 26th Annual Healthcare Conference

LOS ANGELES, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on...
November 21, 2014 08:00 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Clinical Data Update at American Society of Hematology Annual Meeting

LOS ANGELES, Nov. 21, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs)...
November 12, 2014 16:05 ET | Source: Lion Biotechnologies, Inc.

Lion Biotechnologies Announces Management Change

LOS ANGELES, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...